Responses
Obstetrics and gynaecology
Protocol
Phase I pilot clinical trial of antenatal maternally administered melatonin to decrease the level of oxidative stress in human pregnancies affected by pre-eclampsia (PAMPR): study protocol
Compose a Response to This Article
Other responses
No responses have been published for this article.